Publication | Open Access

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

Manufacturer PerspectivesPersonalized Medicine—payerHealthcare ValueHealth PolicyHealth EconomicsHealth Care ReimbursementPersonalized TreatmentOutcomes ResearchHealth Services CompetitionPharmacoeconomicsHealth Care CostHealth Care FinanceHealth ReimbursementEconomic EvaluationMedicineInsurance RegulationsPublic HealthHealth Services Research